These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

657 related items for PubMed ID: 17630117

  • 1. Histopathology of endometrial hyperplasia and endometrial carcinoma: an update.
    Horn LC, Meinel A, Handzel R, Einenkel J.
    Ann Diagn Pathol; 2007 Aug; 11(4):297-311. PubMed ID: 17630117
    [Abstract] [Full Text] [Related]

  • 2. Molecular carcinogenesis of endometrial cancer.
    Liu FS.
    Taiwan J Obstet Gynecol; 2007 Mar; 46(1):26-32. PubMed ID: 17389185
    [Abstract] [Full Text] [Related]

  • 3. Histopathology of endometrial hyperplasia and endometrial carcinoma. An update by Dr LC Horn et al in Annals of Diagnostic Pathology 2007;11:297-311.
    Zheng W, Chambers SK.
    Ann Diagn Pathol; 2008 Jun; 12(3):231-2; author reply 232-3. PubMed ID: 18486902
    [No Abstract] [Full Text] [Related]

  • 4. [Precancerous lesion of the endometrium and endometrial morphology in patients with tamoxifen therapy].
    Schmidt D, Horn LC.
    Zentralbl Gynakol; 2002 Jan; 124(1):3-9. PubMed ID: 11873307
    [Abstract] [Full Text] [Related]

  • 5. Theories of endometrial carcinogenesis: a multidisciplinary approach.
    Sherman ME.
    Mod Pathol; 2000 Mar; 13(3):295-308. PubMed ID: 10757340
    [Abstract] [Full Text] [Related]

  • 6. Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer.
    Amant F, Cadron I, Fuso L, Berteloot P, de Jonge E, Jacomen G, Van Robaeys J, Neven P, Moerman P, Vergote I.
    Gynecol Oncol; 2005 Aug; 98(2):274-80. PubMed ID: 15972232
    [Abstract] [Full Text] [Related]

  • 7. [Morphologic endometrium changes with tamoxifen].
    Dallenbach-Hellweg G, Hahn U, Schmidt D.
    Zentralbl Gynakol; 1996 Aug; 118(6):365-9. PubMed ID: 8768015
    [Abstract] [Full Text] [Related]

  • 8. A dualistic model for endometrial carcinogenesis based on immunohistochemical and molecular genetic analyses.
    Lax SF, Kurman RJ.
    Verh Dtsch Ges Pathol; 1997 Aug; 81():228-32. PubMed ID: 9474874
    [Abstract] [Full Text] [Related]

  • 9. Poly(ADP-ribose) polymerase (PARP) and DNA-fragmentation factor (DFF45): expression and correlation in normal, hyperplastic and neoplastic endometrial tissues.
    Brustmann H.
    Pathol Res Pract; 2007 Aug; 203(2):65-72. PubMed ID: 17258405
    [Abstract] [Full Text] [Related]

  • 10. [Endometrial carcinoma and precursor lesions].
    Djordjević B, Stanojević Z.
    Srp Arh Celok Lek; 2007 Aug; 135(3-4):230-4. PubMed ID: 17642468
    [Abstract] [Full Text] [Related]

  • 11. [Dualistic model of molecular pathogenesis in endometrial carcinoma].
    Lax SF.
    Zentralbl Gynakol; 2002 Jan; 124(1):10-6. PubMed ID: 11873308
    [Abstract] [Full Text] [Related]

  • 12. Clinicopathologic analysis of 187 high-grade endometrial carcinomas of different histologic subtypes: similar outcomes belie distinctive biologic differences.
    Soslow RA, Bissonnette JP, Wilton A, Ferguson SE, Alektiar KM, Duska LR, Oliva E.
    Am J Surg Pathol; 2007 Jul; 31(7):979-87. PubMed ID: 17592263
    [Abstract] [Full Text] [Related]

  • 13. Endometrial intraepithelial neoplasia (EIN): will it bring order to chaos? The Endometrial Collaborative Group.
    Mutter GL.
    Gynecol Oncol; 2000 Mar; 76(3):287-90. PubMed ID: 10684697
    [Abstract] [Full Text] [Related]

  • 14. Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression.
    Lax SF, Pizer ES, Ronnett BM, Kurman RJ.
    Hum Pathol; 1998 Jun; 29(6):551-8. PubMed ID: 9635673
    [Abstract] [Full Text] [Related]

  • 15. Expression pattern of osteopontin in endometrial carcinoma: correlation with expression of the adhesion molecule CEACAM1.
    Briese J, Schulte HM, Bamberger CM, Löning T, Bamberger AM.
    Int J Gynecol Pathol; 2006 Apr; 25(2):161-9. PubMed ID: 16633066
    [Abstract] [Full Text] [Related]

  • 16. Analysis of histopathological features of endometrioid uterine carcinomas and epidemiologic risk factors.
    Sturgeon SR, Sherman ME, Kurman RJ, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wilbanks GD, Brinton LA.
    Cancer Epidemiol Biomarkers Prev; 1998 Mar; 7(3):231-5. PubMed ID: 9521439
    [Abstract] [Full Text] [Related]

  • 17. [New features in the 2014 WHO classification of uterine neoplasms].
    Lax SF.
    Pathologe; 2016 Nov; 37(6):500-511. PubMed ID: 27738815
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Endometrial carcinomas: a review emphasizing overlapping and distinctive morphological and immunohistochemical features.
    Bartosch C, Manuel Lopes J, Oliva E.
    Adv Anat Pathol; 2011 Nov; 18(6):415-37. PubMed ID: 21993268
    [Abstract] [Full Text] [Related]

  • 20. [Pathology of the endometrium in breast cancer patients treated with tamoxifen (nolvadex)].
    Ivanova V, Karaivanov M, Marinov E, Gorchev G, Velkova A, Khristova P.
    Akush Ginekol (Sofiia); 2003 Nov; 42(5):3-8. PubMed ID: 14682005
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.